When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Prelude Therapeutics (PRLD) has priced upsized public offering of ~2.21M shares (from 1.75M) of its voting common stock and 291,666 of non-voting common stock, each at $60.00/share, for expected gross proceeds of $150M.Underwriters' over-allotment is an additional 375K shares of voting common stock. Morgan Stanley, Goldman Sachs, BofA Securities and Barclays are acting as joint book-running managers.Closing date is January 11.